Drugs / CsA
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02677181 Background | Jan 2016 → Jan 2020 | acute graft versus host disease | Chinese PLA General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CsA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02677181 ↗ |
| Route | Intravenous | “cyclosporine (3 mg/kg, q12h, i.v.) was used from day -9” NCT02677181 ↗ |